G Giaccone, R Musella, M Donadio, A Boidi-Trotti, O Bertetto, F Fracchia, A Tardy, A Calciati
{"title":"胸部照射改善小细胞肺癌诱导化疗后疗效的尝试。","authors":"G Giaccone, R Musella, M Donadio, A Boidi-Trotti, O Bertetto, F Fracchia, A Tardy, A Calciati","doi":"10.3109/02841868509134419","DOIUrl":null,"url":null,"abstract":"<p><p>Forty-six patients with small cell lung carcinoma received cyclic chemotherapy with cisplatin-VP 16 and vincristine, doxorubicin, and cyclophosphamide. The responding patients were given prophylactic cranial irradiation. Patients without metastases not achieving a complete response (CR) following induction chemotherapy were given chest irradiation. The response rate was 73.9 per cent. Response was improved by radiation therapy in only 9 per cent of the patients with limited disease. Median survival was 39 weeks, with 2 patients surviving for longer than 24 months. The duration of response and survival in complete and partial responders was similar; absence of radiation therapy in the patients with CR might explain this finding.</p>","PeriodicalId":77655,"journal":{"name":"Acta radiologica. Oncology","volume":"24 6","pages":"475-9"},"PeriodicalIF":0.0000,"publicationDate":"1985-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/02841868509134419","citationCount":"4","resultStr":"{\"title\":\"Chest irradiation as an attempt to improve the response after induction chemotherapy in small cell lung carcinoma.\",\"authors\":\"G Giaccone, R Musella, M Donadio, A Boidi-Trotti, O Bertetto, F Fracchia, A Tardy, A Calciati\",\"doi\":\"10.3109/02841868509134419\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Forty-six patients with small cell lung carcinoma received cyclic chemotherapy with cisplatin-VP 16 and vincristine, doxorubicin, and cyclophosphamide. The responding patients were given prophylactic cranial irradiation. Patients without metastases not achieving a complete response (CR) following induction chemotherapy were given chest irradiation. The response rate was 73.9 per cent. Response was improved by radiation therapy in only 9 per cent of the patients with limited disease. Median survival was 39 weeks, with 2 patients surviving for longer than 24 months. The duration of response and survival in complete and partial responders was similar; absence of radiation therapy in the patients with CR might explain this finding.</p>\",\"PeriodicalId\":77655,\"journal\":{\"name\":\"Acta radiologica. Oncology\",\"volume\":\"24 6\",\"pages\":\"475-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1985-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3109/02841868509134419\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta radiologica. Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/02841868509134419\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta radiologica. Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/02841868509134419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Chest irradiation as an attempt to improve the response after induction chemotherapy in small cell lung carcinoma.
Forty-six patients with small cell lung carcinoma received cyclic chemotherapy with cisplatin-VP 16 and vincristine, doxorubicin, and cyclophosphamide. The responding patients were given prophylactic cranial irradiation. Patients without metastases not achieving a complete response (CR) following induction chemotherapy were given chest irradiation. The response rate was 73.9 per cent. Response was improved by radiation therapy in only 9 per cent of the patients with limited disease. Median survival was 39 weeks, with 2 patients surviving for longer than 24 months. The duration of response and survival in complete and partial responders was similar; absence of radiation therapy in the patients with CR might explain this finding.